Treating Acute Decompensated Heart Failure in Patients with COVID-19 Using Intravenous Nitroglycerin in 5% Glutathione

The purpose of this current opinion article is to illustrate a novel approach to the treatment of acute decompensated heart failure (ADHF) in coronavirus disease 2019 (COVID-19) patients. The approach described herein relies on a reformulation of intravenous nitroglycerin in 5% glutathione, itself n...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaesemeyer, Wayne, Suvorava, Tatsiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982335/
https://www.ncbi.nlm.nih.gov/pubmed/33748918
http://dx.doi.org/10.1007/s40256-021-00474-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982335/
https://www.ncbi.nlm.nih.gov/pubmed/33748918
http://dx.doi.org/10.1007/s40256-021-00474-w

Ejemplares similares